{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:39:44Z","timestamp":1794224384825,"version":"4.8.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Periampullary cancers are uncommon malignancies, often amenable to surgery. Several studies have suggested a role for adjuvant chemotherapy and chemoradiotherapy in improving survival of patients with periampullary cancers, with variable results. The aim of this meta-analysis was to determine the survival benefit of adjuvant therapy for periampullary cancers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic review was undertaken of literature published between 1 January 2000 and 31 December 2015 to elicit and analyse the pooled overall survival associated with the use of either adjuvant chemotherapy or chemoradiotherapy versus observation in the treatment of surgically resected periampullary cancer. Included articles were also screened for information regarding stage, prognostic factors and toxicity-related events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 704 titles were screened, of which 93 full-text articles were retrieved. Fourteen full-text articles were included in the study, six of which were RCTs. A total of 1671 patients (904 in the control group and 767 who received adjuvant therapy) were included. The median 5-year overall survival rate was 37\u00b75 per cent in the control group, compared with 40\u00b70 per cent in the adjuvant group (hazard ratio 1\u00b708, 95 per cent c.i. 0\u00b791 to 1\u00b728; P = 0\u00b7067). In 32\u00b72 per cent of patients who had adjuvant therapy, one or more WHO grade 3 or 4 toxicity-related events were noted. Advanced T category was associated worse survival (regression coefficient \u22120\u00b714, P = 0\u00b7040), whereas nodal status and grade of differentiation were not.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This systematic review found no associated survival benefit for adjuvant chemotherapy or chemoradiotherapy in the treatment of periampullary cancer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/bjs.10563","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T16:27:04Z","timestamp":1495124824000},"page":"814-822","source":"Crossref","is-referenced-by-count":53,"title":["Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma"],"prefix":"10.1093","volume":"104","author":[{"given":"A","family":"Acharya","sequence":"first","affiliation":[{"name":"Division of Surgery, Department of Surgery and Cancer, St Mary's Hospital, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"Markar","sequence":"additional","affiliation":[{"name":"Division of Surgery, Department of Surgery and Cancer, St Mary's Hospital, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Sodergren","sequence":"additional","affiliation":[{"name":"Division of Surgery, Department of Surgery and Cancer, St Mary's Hospital, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Malietzis","sequence":"additional","affiliation":[{"name":"Division of Surgery, Department of Surgery and Cancer, St Mary's Hospital, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Darzi","sequence":"additional","affiliation":[{"name":"Division of Surgery, Department of Surgery and Cancer, St Mary's Hospital, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Athanasiou","sequence":"additional","affiliation":[{"name":"Division of Surgery, Department of Surgery and Cancer, St Mary's Hospital, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Z","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, Royal Marsden Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"2021070910330151400_bjs10563-bib-0001","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.canep.2012.03.010","article-title":"Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007","volume":"36","author":"Coupland","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"2021070910330151400_bjs10563-bib-0002","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s11605-011-1518-6","article-title":"The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma","volume":"15","author":"Showalter","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"2021070910330151400_bjs10563-bib-0003","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijrobp.2008.11.067","article-title":"Role of adjuvant chemoradiotherapy for ampulla of Vater cancer","volume":"75","author":"Kim","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021070910330151400_bjs10563-bib-0004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":"Effect of adjuvant chemotherapy with fluorouracil plus folic acid or gemcitabine vs observation on survival in patients with resected peri-ampullary adenocarcinoma","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"JAMA"},{"key":"2021070910330151400_bjs10563-bib-0005","volume-title":"Incidence and Survival of Ampulla of Vater and Duodenal Cancers","author":"Public Health England","year":"2016"},{"key":"2021070910330151400_bjs10563-bib-0006","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19870615)59:12<2006::AID-CNCR2820591206>3.0.CO;2-B","article-title":"Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer","volume":"59","author":"Gastrointestinal Tumor Study Group","year":"1987","journal-title":"Cancer"},{"key":"2021070910330151400_bjs10563-bib-0007","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ijrobp.2007.07.2327","article-title":"Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of Vater","volume":"70","author":"Krishnan","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021070910330151400_bjs10563-bib-0008","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s12032-009-9351-4","article-title":"The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater","volume":"27","author":"Kim","year":"2010","journal-title":"Med Oncol"},{"key":"2021070910330151400_bjs10563-bib-0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"2021070910330151400_bjs10563-bib-0010","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2021070910330151400_bjs10563-bib-0011","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"2021070910330151400_bjs10563-bib-0012","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"2021070910330151400_bjs10563-bib-0013","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijrobp.2006.04.018","article-title":"Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience","volume":"66","author":"Bhatia","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021070910330151400_bjs10563-bib-0014","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0360-3016(00)00537-X","article-title":"Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas","volume":"47","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021070910330151400_bjs10563-bib-0015","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group","volume":"6","author":"Klikenbijl","year":"1999","journal-title":"Ann Surg"},{"key":"2021070910330151400_bjs10563-bib-0016","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ejso.2011.06.008","article-title":"Predictors of clinical outcomes of resected ampullary adenocarcinoma: a single-institution experience","volume":"37","author":"Lazaryan","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"2021070910330151400_bjs10563-bib-0017","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/SLA.0b013e318190c53e","article-title":"Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer","volume":"248","author":"Morak","year":"2008","journal-title":"Ann Surg"},{"key":"2021070910330151400_bjs10563-bib-0018","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1748-717X-6-126","article-title":"Evaluation of adjuvant chemoradiation therapy for ampulary adenocarcinoma: the John Hopkins Hospital\u2013Mayo Clinic collaborative study","volume":"6","author":"Narang","year":"2011","journal-title":"Radiat Oncol"},{"key":"2021070910330151400_bjs10563-bib-0019","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized control trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"2021070910330151400_bjs10563-bib-0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.surg.2015.02.001","article-title":"Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater","volume":"158","author":"Schiergens","year":"2015","journal-title":"Surgery"},{"key":"2021070910330151400_bjs10563-bib-0021","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejso.2004.08.013","article-title":"Adjuvant chemo-radiotherapy in ampullary cancers","volume":"31","author":"Sikora","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"2021070910330151400_bjs10563-bib-0022","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/SLA.0b013e318156eef3","article-title":"Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation","volume":"246","author":"Smeenk","year":"2007","journal-title":"Ann Surg"},{"key":"2021070910330151400_bjs10563-bib-0023","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"2021070910330151400_bjs10563-bib-0024","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.radonc.2009.05.006","article-title":"Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater","volume":"92","author":"Zhou","year":"2009","journal-title":"Radiother Oncol"},{"key":"2021070910330151400_bjs10563-bib-0025","doi-asserted-by":"crossref","first-page":"970234","DOI":"10.1155\/2014\/970234","article-title":"Prognostic factors for long-term survival in patients with ampullary carcinoma: the results of a 15-year observation period after pancreaticoduodenecotmy","volume":"2014","author":"Klein","year":"2014","journal-title":"HPB Surg"},{"key":"2021070910330151400_bjs10563-bib-0026","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archsurg.140.6.529","article-title":"Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer","volume":"140","author":"Brown","year":"2005","journal-title":"Arch Surg"},{"key":"2021070910330151400_bjs10563-bib-0027","author":"National Cancer Institute","year":"2016","journal-title":"Common Terminology Criteria for Adverse Events (CTCAE)"},{"key":"2021070910330151400_bjs10563-bib-0028","author":"Cancer Research UK","year":"2016","journal-title":"Fluorouracil"},{"key":"2021070910330151400_bjs10563-bib-0029","doi-asserted-by":"crossref","first-page":"14 733","DOI":"10.3748\/wjg.v20.i40.14733","article-title":"Adjuvant therapy in pancreatic cancer","volume":"20","author":"Jones","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2021070910330151400_bjs10563-bib-0030","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"JAMA"},{"key":"2021070910330151400_bjs10563-bib-0031","first-page":"8","article-title":"The role of local excision in invasive adenocarcinoma of the ampulla of Vater","volume":"4","author":"Zhong","year":"2013","journal-title":"J Gastrointest Oncol"},{"key":"2021070910330151400_bjs10563-bib-0032","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1016\/j.ijrobp.2005.07.287","article-title":"Carcinoma of the ampulla of Vater: patterns of failure after resection and possible benefit of adjuvant radiotherapy","volume":"63","author":"Czito","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021070910330151400_bjs10563-bib-0033","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ejso.2015.01.010","article-title":"Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort","volume":"41","author":"Colussi","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"2021070910330151400_bjs10563-bib-0034","first-page":"583","article-title":"Perineural invasion and peroperative serum CA19-9 as predictors of survival in biliary tract cancer","volume":"33","author":"Kawamata","year":"2013","journal-title":"Anticancer Res"},{"key":"2021070910330151400_bjs10563-bib-0035","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1245\/s10434-012-2245-2","article-title":"Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullar carcinoma","volume":"19","author":"Sakabe","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"2021070910330151400_bjs10563-bib-0036","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jclinpath-2015-203337","article-title":"Immunophenotyping of ampullary carcinomata allows for treatment specific subgroups","volume":"69","author":"Leo","year":"2016","journal-title":"J Clin Pathol"},{"key":"2021070910330151400_bjs10563-bib-0037","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3109\/00365521.2011.610006","article-title":"Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?","volume":"46","author":"Amptoulach","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"2021070910330151400_bjs10563-bib-0038","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/annonc\/mdt191","article-title":"A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy","volume":"24","author":"Jiang","year":"2013","journal-title":"Ann Oncol"},{"key":"2021070910330151400_bjs10563-bib-0039","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs.10563","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/104\/7\/814\/37945687\/bjs10563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/104\/7\/814\/37945687\/bjs10563.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T19:59:24Z","timestamp":1625860764000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/104\/7\/814\/6095083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,5,18]]},"published-print":{"date-parts":[[2017,5,18]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs.10563","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6]]},"published":{"date-parts":[[2017,5,18]]}}}